Assessment of Implantable Cardioverter-Defibrillator Used in Heart Failure with Reduced Ejection Fraction as Primary Prevention in an Underserved Population

J Gen Intern Med. 2018 Nov;33(11):1854-1856. doi: 10.1007/s11606-018-4544-1.

Authors

Yifan Lu¹, Ningxin Wan¹, Nidhi Madan¹, Ninel Hovnanians¹, Juan Carlos Ruiz Diaz¹, Panagiota Christia¹, Robert Faillace²

Affiliations

¹ Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.
² Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA. robert.faillace@nbhn.net.

No abstract available

Publication types

Letter

MeSH terms

Aged
Cohort Studies
Defibrillators, Implantable / trends*
Female
Follow-Up Studies
Heart Failure / diagnosis
Heart Failure / epidemiology*
Heart Failure / therapy*
Humans
Male
Middle Aged
Primary Prevention / methods
Primary Prevention / trends*
Retrospective Studies
Stroke Volume / physiology*
Vulnerable Populations*